• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用 TMLE 方法估计泰格尔伯格医院 ICU 中危重症 COVID-19 患者使用地塞米松与氢化可的松对中性粒细胞-淋巴细胞比值的因果效应。

Estimating the causal effect of dexamethasone versus hydrocortisone on the neutrophil- lymphocyte ratio in critically ill COVID-19 patients from Tygerberg Hospital ICU using TMLE method.

机构信息

Division of Epidemiology and Biostatistics, Department of Global Health, Stellenbosch University, 3rd Floor, Education Building, Francie Van Zijl Drive, Parow, Cape Town, 7500, South Africa.

Biostatistics Research Group (BRG), Mikro Park, Kuilsriver, Cape Town, South Africa.

出版信息

BMC Infect Dis. 2024 Nov 29;24(1):1365. doi: 10.1186/s12879-024-10112-w.

DOI:10.1186/s12879-024-10112-w
PMID:39609735
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11606140/
Abstract

BACKGROUND

Causal inference from observational studies is an area of interest to researchers, advancing rapidly over the years and with it, the methods for causal effect estimation. Among them, Targeted Maximum Likelihood estimation (TMLE) possesses arguably the most outstanding statistical properties, and with no outright treatment for COVID-19, there was an opportunity to estimate the causal effect of dexamethasone versus hydrocortisone upon the neutrophil-lymphocyte ratio (NLR), a vital indicator for disease progression among critically ill COVID-19 patients.

METHODS

TMLE variations were used in the analysis. Super Learner (SL), Bayesian Additive Regression Trees (BART) and parametric regression (PAR) were implemented to estimate the average treatment effect (ATE).

RESULTS

The study had 168 participants, 128 on dexamethasone and 40 on hydrocortisone. The mean causal difference in NLR on day 5; ATE [95% CI]: from SL-TMLE was - 0.309 [-3.800, 3.182] BART-TMLE 0.246 [-3.399, 3.891] and PAR-TMLE 1.245 [-1.882, 4372]. The ATE of dexamethasone versus hydrocortisone on NLR was not statistically significant since the confidence interval included zero.

CONCLUSION

The effect of dexamethasone is not significantly different from that of hydrocortisone on NLR in critically ill COVID-19 patients admitted to ICU. This implies that the difference in effect on NLR between the two drugs is due to random chance. TMLE remains an outstanding approach for causal analysis of observational studies with the ability to be augmented with multiple prediction approaches.

摘要

背景

从观察性研究中进行因果推断是研究人员感兴趣的一个领域,多年来一直在快速发展,因果效应估计方法也在不断发展。其中,靶向最大似然估计(TMLE)具有最突出的统计特性,由于目前还没有针对 COVID-19 的明确治疗方法,因此有机会估计地塞米松与氢化可的松对中性粒细胞与淋巴细胞比值(NLR)的因果效应,NLR 是危重症 COVID-19 患者疾病进展的重要指标。

方法

在分析中使用了 TMLE 的变化。超级学习者(SL)、贝叶斯加法回归树(BART)和参数回归(PAR)被用来估计平均治疗效果(ATE)。

结果

这项研究有 168 名参与者,其中 128 名接受地塞米松治疗,40 名接受氢化可的松治疗。第 5 天 NLR 的平均因果差异;ATE[95%CI]:来自 SL-TMLE 的为-0.309[-3.800, 3.182],BART-TMLE 为 0.246[-3.399, 3.891],PAR-TMLE 为 1.245[-1.882, 4372]。地塞米松与氢化可的松对 NLR 的 ATE 无统计学意义,因为置信区间包含零。

结论

地塞米松对 ICU 收治的危重症 COVID-19 患者的 NLR 没有显著影响。这意味着两种药物对 NLR 的影响差异是由于随机机会造成的。TMLE 仍然是一种出色的观察性研究因果分析方法,它可以与多种预测方法相结合。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/673e/11606140/41c74557c1db/12879_2024_10112_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/673e/11606140/e40f205fa8cb/12879_2024_10112_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/673e/11606140/41c74557c1db/12879_2024_10112_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/673e/11606140/e40f205fa8cb/12879_2024_10112_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/673e/11606140/41c74557c1db/12879_2024_10112_Fig2_HTML.jpg

相似文献

1
Estimating the causal effect of dexamethasone versus hydrocortisone on the neutrophil- lymphocyte ratio in critically ill COVID-19 patients from Tygerberg Hospital ICU using TMLE method.使用 TMLE 方法估计泰格尔伯格医院 ICU 中危重症 COVID-19 患者使用地塞米松与氢化可的松对中性粒细胞-淋巴细胞比值的因果效应。
BMC Infect Dis. 2024 Nov 29;24(1):1365. doi: 10.1186/s12879-024-10112-w.
2
Effect of Hydrocortisone on 21-Day Mortality or Respiratory Support Among Critically Ill Patients With COVID-19: A Randomized Clinical Trial.COVID-19 重症患者中氢化可的松对 21 天死亡率或呼吸支持的影响:一项随机临床试验。
JAMA. 2020 Oct 6;324(13):1298-1306. doi: 10.1001/jama.2020.16761.
3
Prognostic role of Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio in critically ill COVID-19 patients: A retrospective study.中性粒细胞与淋巴细胞比值和血小板与淋巴细胞比值对危重症 COVID-19 患者预后的预测作用:一项回顾性研究。
Med J Malaysia. 2024 Nov;79(6):743-748.
4
Targeted Maximum Likelihood Estimation for Causal Inference in Observational Studies.观察性研究中因果推断的靶向最大似然估计
Am J Epidemiol. 2017 Jan 1;185(1):65-73. doi: 10.1093/aje/kww165. Epub 2016 Dec 9.
5
Association between different corticosteroid regimens used in severe SARS-CoV-2 infection and short-term mortality: retrospective cohort study.严重 SARS-CoV-2 感染中使用的不同皮质类固醇方案与短期死亡率之间的关联:回顾性队列研究。
Rev Esp Anestesiol Reanim (Engl Ed). 2024 May;71(5):379-386. doi: 10.1016/j.redare.2024.02.012. Epub 2024 Feb 21.
6
A comparative study between methylprednisolone versus dexamethasone as an initial anti-inflammatory treatment of moderate COVID-19 pneumonia: an open-label randomized controlled trial.甲泼尼龙与地塞米松作为中重度 COVID-19 肺炎初始抗炎治疗的对比研究:一项开放标签随机对照试验。
BMC Pulm Med. 2024 Nov 11;24(1):562. doi: 10.1186/s12890-024-03364-4.
7
Collaborative double robust targeted maximum likelihood estimation.协作双稳健靶向最大似然估计
Int J Biostat. 2010 May 17;6(1):Article 17. doi: 10.2202/1557-4679.1181.
8
Corticosteroids in critical COVID-19: Are all corticosteroids equal?皮质类固醇治疗危重症 COVID-19:所有皮质类固醇都一样吗?
S Afr Med J. 2021 Apr 6;111(6):550-553.
9
Association Between Dexamethasone and Delirium in Critically Ill Patients: A Retrospective Cohort Study of a Large Clinical Database.地塞米松与危重症患者谵妄的关联:一项大型临床数据库的回顾性队列研究。
J Surg Res. 2021 Jul;263:89-101. doi: 10.1016/j.jss.2021.01.027. Epub 2021 Feb 24.
10
Short term survival of critically ill COVID-19 Egyptian patients on assisted ventilation treated by either Dexamethasone or Tocilizumab.地塞米松或托珠单抗治疗的埃及危重症 COVID-19 患者辅助通气的短期存活率。
Sci Rep. 2021 Apr 23;11(1):8816. doi: 10.1038/s41598-021-88086-x.

本文引用的文献

1
Practical considerations for specifying a super learner.指定超级学习者的实用考虑因素。
Int J Epidemiol. 2023 Aug 2;52(4):1276-1285. doi: 10.1093/ije/dyad023.
2
Comparing g-computation, propensity score-based weighting, and targeted maximum likelihood estimation for analyzing externally controlled trials with both measured and unmeasured confounders: a simulation study.比较 g 计算、倾向评分加权和有测量和未测量混杂因素的外部对照试验的靶向极大似然估计:一项模拟研究。
BMC Med Res Methodol. 2023 Jan 17;23(1):18. doi: 10.1186/s12874-023-01835-6.
3
Haematological predictors of poor outcome among COVID-19 patients admitted to an intensive care unit of a tertiary hospital in South Africa.
南非一家三级医院重症监护病房的 COVID-19 患者预后不良的血液学预测因子。
PLoS One. 2022 Nov 4;17(11):e0275832. doi: 10.1371/journal.pone.0275832. eCollection 2022.
4
Prognostic value of biochemical parameters among severe COVID-19 patients admitted to an intensive care unit of a tertiary hospital in South Africa.南非一家三级医院重症监护病房收治的重症 COVID-19 患者生化指标的预后价值。
IJID Reg. 2022 Mar;2:191-197. doi: 10.1016/j.ijregi.2022.01.012. Epub 2022 Jan 23.
5
A Prognostic Model Using Post-Steroid Neutrophil-Lymphocyte Ratio Predicts Overall Survival in Primary Central Nervous System Lymphoma.使用类固醇后中性粒细胞与淋巴细胞比值的预后模型可预测原发性中枢神经系统淋巴瘤的总生存期。
Cancers (Basel). 2022 Apr 3;14(7):1818. doi: 10.3390/cancers14071818.
6
Corticosteroids in critical COVID-19: Are all corticosteroids equal?皮质类固醇治疗危重症 COVID-19:所有皮质类固醇都一样吗?
S Afr Med J. 2021 Apr 6;111(6):550-553.
7
Dexamethasone vs methylprednisolone high dose for Covid-19 pneumonia.地塞米松与甲泼尼龙大剂量治疗新冠肺炎肺炎。
PLoS One. 2021 May 25;16(5):e0252057. doi: 10.1371/journal.pone.0252057. eCollection 2021.
8
Corticosteroids in SARS-COV2 infection: certainties and uncertainties in clinical practice.COVID-19 感染中的皮质类固醇:临床实践中的确定性和不确定性。
Expert Rev Anti Infect Ther. 2021 Dec;19(12):1553-1562. doi: 10.1080/14787210.2021.1933437. Epub 2021 Jun 1.
9
Current evidence for COVID-19 therapies: a systematic literature review.当前针对 COVID-19 的治疗方法的证据:一项系统文献综述。
Eur Respir Rev. 2021 Mar 17;30(159). doi: 10.1183/16000617.0384-2020. Print 2021 Mar 31.
10
The Neutrophil-to-Lymphocyte Ratio Determines Clinical Efficacy of Corticosteroid Therapy in Patients with COVID-19.中性粒细胞与淋巴细胞比值可预测 COVID-19 患者糖皮质激素治疗的临床疗效。
Cell Metab. 2021 Feb 2;33(2):258-269.e3. doi: 10.1016/j.cmet.2021.01.002. Epub 2021 Jan 5.